Publication | Closed Access

Differential efficacy of human recombinant interferon-α2a on ocular and extraocular manifestations of behçet disease: results of an open 4-center trial

Behçet DiseaseOcular DiseaseAutoimmune DiseaseOphthalmologyImmunodeficienciesImmunologyPathologyAutoimmunityImmunologic DiseaseOcular PathologyImmunotherapyMedicineDifferential EfficacyOpen 4-Center Trial